First Time Loading...

Nkarta Inc
NASDAQ:NKTX

Watchlist Manager
Nkarta Inc Logo
Nkarta Inc
NASDAQ:NKTX
Watchlist
Price: 7.49 USD 12.13% Market Closed
Updated: May 2, 2024

Wall Street
Price Targets

NKTX Price Targets Summary
Nkarta Inc

Wall Street analysts forecast NKTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NKTX is 19.64 USD with a low forecast of 15.15 USD and a high forecast of 26.25 USD.

Lowest
Price Target
15.15 USD
102% Upside
Average
Price Target
19.64 USD
162% Upside
Highest
Price Target
26.25 USD
250% Upside

NKTX Last Price Targets
Nkarta Inc

The latest public price target was made on Mar 26, 2024 by Bill Maughan from Canaccord Genuity , who expects NKTX stock to rise by 114% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Bill Maughan
Canaccord Genuity
16 USD
Upside 114%
1 month ago
Mar 26, 2024
Nkarta Inc. (NKTX) PT Raised to $16 at Canaccord Genuity
StreetInsider
Gil Blum
Needham
15 USD
Upside 100%
1 month ago
Mar 22, 2024
These Analysts Revise Their Forecasts On Nkarta After Q4 Results
Benzinga
Salim Syed
Mizuho Securities
25 USD
Upside 234%
1 month ago
Mar 22, 2024
Nkarta Inc. (NKTX) PT Lowered to $25 at Mizuho on deprioritization of NKX101
StreetInsider
Laura Prendergast
Raymond James
16 USD
Upside 114%
1 month ago
Mar 22, 2024
Raymond James Downgrades Nkarta Inc. (NKTX) to Outperform
StreetInsider
Bill Maughan
Canaccord Genuity
Price Target 16 USD
Upside/Downside 114%
View Source
Gil Blum
Needham
Price Target 15 USD
Upside/Downside 100%
View Source
Salim Syed
Mizuho Securities
Price Target 25 USD
Upside/Downside 234%
View Source
Laura Prendergast
Raymond James
Price Target 16 USD
Upside/Downside 114%
View Source
Nkarta Inc Competitors:
Price Targets
KURN
Kuros Biosciences AG
209% Upside
NGNE
Neurogene Inc
50% Upside
IPSC
Century Therapeutics Inc
398% Upside
GTH
Genetron Holdings Ltd
67% Downside
302440
SK Bioscience Co Ltd
6% Downside
REGN
Regeneron Pharmaceuticals Inc
18% Upside
MNKD
MannKind Corp
66% Upside
LYEL
Lyell Immunopharma Inc
163% Upside

Revenue
Forecast

Revenue Estimate
Nkarta Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Nkarta Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Nkarta Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-47%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NKTX's stock price target?
Price Target
19.64 USD

According to Wall Street analysts, the average 1-year price target for NKTX is 19.64 USD with a low forecast of 15.15 USD and a high forecast of 26.25 USD.